Search results for "Adverse effect"

showing 10 items of 1065 documents

Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebiotics.

2006

Abstract Objectives The larger number of bifidobacteria in the intestine of breast-fed infants has been associated with their better health compared with formula-fed infants. We assessed the safety and tolerability of an experimental formula containing 2 × 10 7 colony-forming units of Bifidobacterium longum BL999 and 4 g/L of a prebiotic mixture containing 90% galacto-oligosaccharides and 10% fructo-oligosaccharides. Methods A 7-mo prospective, randomized, reference-controlled, double-blinded trial was performed in infants who were not breast fed after the 14th day of birth. One hundred thirty-eight infants were enrolled and assigned to receive the control or experimental formula until they…

Malemedicine.medical_specialtyBifidobacterium longumEndocrinology Diabetes and Metabolismmedicine.medical_treatmentColony Count MicrobialOligosaccharidesBiologyWeight GainGastroenterologylaw.inventionRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineHumansFood scienceProspective StudiesProspective cohort studyAdverse effectInfant Nutritional Physiological PhenomenaRespiratory Tract InfectionsNutrition and DieteticsPrebioticProbioticsInfant NewbornInfantbiology.organism_classificationBody HeightInfant FormulaIntestinesInfant formulaTolerabilityConsumer Product SafetyFemaleBifidobacteriummedicine.symptomWeight gainConstipationHeadNutrition (Burbank, Los Angeles County, Calif.)
researchProduct

Lethal Anaphylactic Reaction to Intravenous Gelatin in the Course of Surgery

2016

Plasma volume expanders (PVEs) are widely used to increase circulating blood volume. Gelatins used as PVEs are heterogeneous mixtures of polypeptides, usually prepared by hydrolysis of bovine collagen containing large amounts of proline and hydroxyproline residues. It has been shown that gelatins can cause anaphylactic reactions. We describe the case of a 73-year-old man who during surgery for intestinal obstruction presented a lethal anaphylactic reaction after the administration of a PVE containing gelatin lysate. The reaction occurred 10 minutes after the start of plasma expander infusion. Then, patient became comatose, and he died without awakening after 76 days. Necroptic aspects and h…

Malemedicine.medical_specialtyBovine collagenfood.ingredientPlasma SubstitutesBlood volumeAdministration IntravenouPlasma expanderGelatinDrug Hypersensitivity03 medical and health sciencesHydroxyprolinechemistry.chemical_compoundFatal Outcome0302 clinical medicinefoodSettore MED/43 - Medicina LegaleAnaphylaximedicineHumansPharmacology (medical)030212 general & internal medicineComaAdverse effectAnaphylaxisAgedPharmacologyIntravenous Gelatinbusiness.industryPlasma SubstituteAnaphylactic reactionAnaphylactic reactionsGeneral MedicineAdverse reactionPlasma expanderSurgeryLethal Anaphylactic Reaction030228 respiratory systemchemistryPlasma volume expandersAnesthesiaGelatinAdministration IntravenousPlasma volume expanders Lethal Anaphylactic Reaction Intravenous GelatinbusinessIntestinal ObstructionHumanAmerican Journal of Therapeutics
researchProduct

Évaluation de la prescription des antalgiques de palier II chez la personne âgée de 75 ans en médecine générale

2017

Although step-2 analgesics (S2A) are recommended when step-1 analgesics (S1A) are ineffective or in cases of moderate to severe pain, their efficacy varies. This study evaluated the place attributed by general practitioners (GPs) to S2A in the treatment of nociceptive pain in elderly persons (EP). Descriptive, transversal and declarative study conducted among GPs in Burgundy. In total, 115 GPs took part in the survey. Among these, 60.8% had at least one consultation/day for pain. After paracetamol, which was systematically preferred, 56.4% prescribed S2A for EP. The reasons for prescribing S2A included pain not relieved by S1A in 93% of cases, another medical treatment or not (42.6%), or th…

Malemedicine.medical_specialtyConstipationNauseaAnalgesic[ SDV.MHEP.GEG ] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyDrug Prescriptionspersonne âgéeAmbulatory careGeneral PractitionersmedicineHumansPain ManagementMedical prescriptionAdverse effectBiological PsychiatryAgedAged 80 and overAnalgesics[SDV.MHEP.GEG] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologybusiness.industryChronic painmedicine.diseaseDrug Utilizationmédecine généraleNeuropsychology and Physiological PsychologyHealth Care Surveysantalgiques de palier IIVomitingPhysical therapyFemaleFranceNeurology (clinical)Chronic PainGeriatrics and Gerontologymedicine.symptombusinessGériatrie et Psychologie Neuropsychiatrie du Viellissement
researchProduct

Effectiveness and tolerability of amidotrizoate for the treatment of constipation resistant to laxatives in advanced cancer patients.

2011

Abstract Context Constipation is a common problem for advanced cancer patients, and is generally inadequately treated. Objectives The aim of this study was to prospectively evaluate the effectiveness and tolerability of amidotrizoate (AM) in patients unresponsive to current laxatives. Methods A consecutive sample of advanced cancer patients was surveyed. Inclusion criteria were no bowel movements for three days despite receiving regular doses of senna or lactulose. AM 50mL was administered orally; the dose could be repeated the day after, based on clinical judgment and/or patients' preference. Age, sex, primary tumor, previous abdominal surgery, chemotherapy and radiotherapy performed in th…

Malemedicine.medical_specialtyConstipationNauseamedicine.medical_treatmentamidotrizoateLaxativeSettore MED/42 - Igiene Generale E ApplicataDiatrizoateSeverity of Illness IndexLactuloseInternal medicineNeoplasmsMedicineHumansAdverse effectGeneral NursingAgedAged 80 and overbusiness.industryCatharticsconstipation in advanced cancer patientMiddle AgedSurgeryAnesthesiology and Pain MedicineTreatment OutcomeTolerabilityDefecationRegression AnalysisFemaletrial clinicoNeurology (clinical)medicine.symptombusinessConstipationAbdominal surgerymedicine.drugJournal of pain and symptom management
researchProduct

Booster vaccination with hexavalent DTPa-HBV-IPV/Hib vaccine in the second year of life is as safe as concomitant DTPa-IPV/Hib + HBV administered sep…

2003

The safety and reactogenicity of a booster dose of GSK Biologicals' hexavalent DTPa-HBV-IPV/Hib vaccine (N=4725) was compared with the separate administration of GSK Biologicals' DTPa-IPV/Hib and HBV vaccines (N=4474) in two open, randomized multicenter studies (A and B). Solicited symptoms occurring within 4 days of vaccination were recorded on diary cards and serious adverse events (SAEs) were collected throughout the study period. In Study A (N=1149), incidences of solicited symptoms were similar in both groups; there were no SAEs either reported within 4 days of vaccination or considered to be causally related to vaccination. In study B (N=8050), where fever was the only solicited sympt…

Malemedicine.medical_specialtyFeverImmunization SecondaryBooster dosemedicine.disease_causecomplex mixturesInternal medicineConfidence IntervalsHumansMulticenter Studies as TopicMedicineHepatitis B VaccinesVaccines CombinedAdverse effectDiphtheria-Tetanus-Pertussis VaccineImmunization ScheduleHaemophilus VaccinesRandomized Controlled Trials as TopicHepatitis B virusBooster (rocketry)ReactogenicityGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPublic Health Environmental and Occupational HealthInfantVaccinationPoliovirus Vaccine InactivatedInfectious DiseasesHib vaccineImmunizationImmunologyMolecular MedicineFemalebusinessVaccine
researchProduct

Impact of Nurses’ Intervention in the Prevention of Falls in Hospitalized Patients

2020

Background: Clinical safety is a crucial component of healthcare quality, focused on identifying and avoiding the risks to which patients are exposed. Among the adverse events that occur in a hospital environment, falls have a large impact (1.9&ndash

Malemedicine.medical_specialtyHealth Toxicology and MutagenesisNurseslcsh:MedicineNurse's RoleArticle03 medical and health sciencesPatient safety0302 clinical medicineIntervention (counseling)Acute careHealth caremedicinepatient safetyHumans030212 general & internal medicineAdverse effectaccident preventionnursing education researchAged030504 nursingbusiness.industryIncidence (epidemiology)lcsh:RPublic Health Environmental and Occupational HealthBayes TheoremMiddle AgedFalling (accident)SpainEmergency medicineFemaleaccidental fallsmedicine.symptom0305 other medical sciencebusinessEducational programhospitalizationInternational Journal of Environmental Research and Public Health
researchProduct

Functional Mitral Regurgitation Predicts Short-Term Adverse Events in Patients With Acute Heart Failure and Reduced Left Ventricular Ejection Fraction

2017

Functional mitral regurgitation (FMR) is a common finding in patients with acute heart failure (AHF) and reduced left ventricular ejection fraction (heart failure and reduced ejection fraction [HFrEF]). However, its clinical impact remains unclear. We aimed to evaluate the association between the severity of FMR after clinical stabilization and short-term adverse outcomes after a hospitalization for AHF. We prospectively included 938 consecutive patients with HFrEF discharged after a hospitalization for AHF, after excluding those with organic valve disease, congenital heart disease, or aortic valve disease. FMR was assessed semiquantitatively by color Doppler analysis of the regurgitant jet…

Malemedicine.medical_specialtyHeart diseaseHeart Ventricles030204 cardiovascular system & hematologyVentricular Function LeftElectrocardiography03 medical and health sciences0302 clinical medicineInternal medicinemedicineClinical endpointHumansIn patientProspective Studies030212 general & internal medicineAdverse effectProspective cohort studyAgedHeart FailureEjection fractionmedicine.diagnostic_testbusiness.industryMitral Valve InsufficiencyStroke VolumePrognosismedicine.diseaseEchocardiography DopplerSurvival RateSpainHeart failureAcute DiseaseCardiologyFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographyFollow-Up StudiesThe American Journal of Cardiology
researchProduct

Single shot spinal anaesthesia with hypobaric bupivacaine for hip fracture repair surgery in the elderly. Randomized, double blinded comparison of 3.…

2014

Arterial hypotension is the most frequent adverse effect of subarachnoid anaesthesia in the elderly sustaining a femoral proximal fracture. Decreasing the local anaesthetic dose reduces the incidence of hypotension but shortens sensory block duration that could be insufficient in some surgical procedures. Sensory block duration could be prolonged using hypobaric local anaesthetics. We evaluated whether low hypobaric bupivacaine doses were adequate for this type of surgery while maintaining the haemodynamic stability.A prospective, randomized, double blinded study was designed. Patients over 65 years old, sustaining traumatic hip fracture, were assigned to one of two groups: B0.5 group, hypo…

Malemedicine.medical_specialtyHemodynamicsCritical Care and Intensive Care MedicineAnesthesia SpinalDouble-Blind MethodHeart ratemedicineHumansProspective StudiesEphedrineAnesthetics LocalAdverse effectAgedBupivacaineAged 80 and overHip fracturebusiness.industryHip FracturesInterim analysismedicine.diseaseBupivacaineSurgeryAnesthesiology and Pain MedicineBlood pressureAnesthesiaFemalebusinessmedicine.drugRevista espanola de anestesiologia y reanimacion
researchProduct

Single shot spinal anesthesia with very low hyperbaric bupivacaine dose (3.75mg) for hip fracture repair surgery in the elderly. A randomized, double…

2014

Single shot spinal anesthesia is used worldwide for hip fracture repair surgery in the elderly. Arterial hypotension is a frequent adverse effect. We hypothesized that lowering local anesthetics dose could decrease the incidence of arterial hypotension, while maintaining quality of surgical anesthesia.In a randomized double blinded study, 66 patients over the age of 65 years, with hip fracture needing surgical repair, were assigned to B0.5 group 7.5mg hyperbaric bupivacaine 5mg/ml (control group), and B0.25 group 3.75mg hyperbaric bupivacaine 2.5mg/ml (study group). Sensory and motor block level, and hemodynamic parameters including blood presure, heart rate and vasopressor dose administrat…

Malemedicine.medical_specialtyHemodynamicsCritical Care and Intensive Care MedicineAnesthesia SpinalFracture Fixation InternalDouble-Blind MethodHeart ratePressuremedicineHumansVasoconstrictor AgentsAnesthetics LocalEphedrineIntraoperative ComplicationsAdverse effectAgedAged 80 and overEphedrineBupivacaineSurgical repairHip fractureDose-Response Relationship DrugHip Fracturesbusiness.industryHemodynamicsmedicine.diseaseBupivacaineSurgeryAnesthesiology and Pain MedicineBlood pressureAnesthesiaFemaleHypotensionbusinessFollow-Up Studiesmedicine.drugRevista Española de Anestesiología y Reanimación
researchProduct

Leucocyte Interferon-alpha for Patients with Chronic Hepatitis C Intolerant to Other alpha-Interferons

2003

Background: Alpha-interferon (α-IFN) is the treatment of choice for chronic hepatitis C but most patients experience adverse effects which sometimes lead to the suspension of therapy. Recently, higher doses of α-IFN or prolonged therapy have increased the number of cases of intolerance. Study Design: In this open study we evaluated the efficacy and safety of leucocyte interferon-alpha (IFNα) [6MU three times a week] in 43 patients with chronic hepatitis C who had been intolerant to previous treatment courses with recombinant or lymphoblastoid IFNα. All patients were treated for 6 months and followed-up for an additional 6 months. End of treatment responders were patients in whom hepatitis C…

Malemedicine.medical_specialtyHepatitis C virusAlpha interferonmedicine.disease_causeAntiviral AgentsInjections IntramuscularGastroenterologyPharmacotherapyInternal medicineLeukocytesHumansImmunology and AllergyMedicinePharmacology (medical)Adverse effectPharmacologybiologybusiness.industryInterferon-alphaGeneral MedicineHepatitis C ChronicMiddle AgedMolecular medicineAnti-thyroid autoantibodiesDiscontinuationPharmacology Toxicology and Pharmaceutics (all)Immunologybiology.proteinFemaleAntibodybusinessBiotechnologyBioDrugs
researchProduct